Jasper Therapeutics Inc JSPRW

Jasper Therapeutics Inc

Biotechnology

Healthcare

JSPRW

37.82M shares

NASDAQ US

traded

07 Jan 2022

open

1.32

52 week high

1.90

high

1.42

52 week low

1.33

low

1.32

growth

-15.29%

previous Close

1.46

P/E ratio

-2

market cap

div yield

0

usd

Jun 2021

qoq

revenue

-3.01M

net incoming

-3.57M

eps

-0.69

17.04 %

eps surprise

0.00 %

net profit margin

118.69 %

118.00 %

operating incoming

-562.03K

net change in cash

-280.88K

cash on hand

310K

cost of revenue